-
1st CF Biosimilar of Dornase Alfa Inhalation Solution Approved in Russia
Generium and Selexis announced that Russia approved the world’s first biosimilar to Pulmozyme, a dornase alfa inhalation solution, to treat CF patients. Read the full story here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.